<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04952935</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-20-7569</org_study_id>
    <nct_id>NCT04952935</nct_id>
  </id_info>
  <brief_title>Acupuncture for the Treatment of Medication-Dependent Hypotension in Heart Failure</brief_title>
  <official_title>Acupuncture for the Treatment of Medication-Dependent Hypotension in Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Scripps Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Scripps Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acupuncture is believed to increase blood pressure in people who struggle with low blood&#xD;
      pressure. This is a common problem facing people with heart failure, and sometimes these&#xD;
      people need to take medications to artificially increase their blood pressure. This study is&#xD;
      designed to determine if using acupuncture in people with heart failure can improve their&#xD;
      blood pressure enough to not require medications to artificially increase blood pressure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 20, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized double-blinded sham-controlled clinical trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Patient receives true or sham acupuncture, and patient is unaware of treatment assignment. Acupuncturist is aware of treatment assignment, as is the statistician who is aware of randomization assignment but not involved otherwise in the execution of clinical trial. Investigators, medical assistants, and patients' physicians are unaware of treatment assignment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>9 weeks</time_frame>
    <description>Change in mean arterial blood pressure, as measured by blood pressure cuff in sitting position</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure adjusted for Medication</measure>
    <time_frame>9 weeks</time_frame>
    <description>Change in mean arterial blood pressure, as measured by blood pressure cuff in sitting position, adjusted for midodrine/fludrocortisone dose as covariate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Standing Blood Pressure adjusted for Medication</measure>
    <time_frame>9 weeks</time_frame>
    <description>Change in mean arterial blood pressure, as measured by blood pressure cuff in standing position, adjusted for midodrine/fludrocortisone dose as covariate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Dose Change</measure>
    <time_frame>9 weeks</time_frame>
    <description>Percentage change in median dose of midodrine or fludrocortisone (in mg per week)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Got off medications</measure>
    <time_frame>9 weeks</time_frame>
    <description>Number of patients who came off of midodrine or fludrocortisone by end of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA Class</measure>
    <time_frame>Start, 5 weeks, and 9 weeks</time_frame>
    <description>Change in NYHA Class</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Score</measure>
    <time_frame>Start, 5 weeks, and 9 weeks</time_frame>
    <description>Change in Quality of Life scores by VAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite Safety Outcome</measure>
    <time_frame>Throughout study, total time 9 weeks</time_frame>
    <description>Composite of skin injury, symptomatic hypotension, hospitalization for heart failure exacerbation or syncope or hypotension, implantation of LVAD/MCS device or heart transplantation, or all-cause death</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Congestive Heart Failure</condition>
  <condition>Hypotension</condition>
  <arm_group>
    <arm_group_label>True Acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Acupuncture</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>True Acupuncture</intervention_name>
    <description>Delivery of four acupuncture seeds (no needles involved) to the head and neck area at true acupuncture points.</description>
    <arm_group_label>True Acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham Acupuncture</intervention_name>
    <description>Delivery of four acupuncture seeds (no needles involved) to the head and neck area at non-acupuncture points.</description>
    <arm_group_label>Sham Acupuncture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age greater than or equal to 18 years old&#xD;
&#xD;
          -  Chronic congestive heart failure (systolic or diastolic)&#xD;
&#xD;
          -  Medication list includes midodrine or fludrocortisone, either taking as scheduled or&#xD;
             as needed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of acupuncture of any kind in the last 3 months&#xD;
&#xD;
          -  Acute decompensated heart failure, as indicated by clinical picture at time of&#xD;
             enrollment&#xD;
&#xD;
          -  Currently on a mechanical device (LVAD, TAH, ECMO)&#xD;
&#xD;
          -  History of hepatorenal syndrome, adrenal insufficiency, for which midodrine and&#xD;
             fludrocortisone respectively is specifically being used to treat that condition&#xD;
&#xD;
          -  Lack of suitable locations for which to place acupuncture seeds&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Suhar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Scripps Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yu-Ming Ni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Scripps Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rajeev Mohan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Scripps Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yu-Ming Ni, MD</last_name>
    <phone>858-554-3360</phone>
    <email>acupunctureHF@scrippshealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christopher Suhar, MD</last_name>
    <phone>858-554-3300</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Scripps La Jolla Medical Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu-Ming Ni, MD</last_name>
      <phone>858-554-3360</phone>
      <email>acupunctureHF@scrippshealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Christopher Suhar, MD</last_name>
      <phone>858-554-3300</phone>
    </contact_backup>
    <investigator>
      <last_name>Yu-Ming Ni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher Suhar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rajeev Mohan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scripps Shiley Integrative Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu-Ming Ni, MD</last_name>
      <phone>858-554-3360</phone>
      <email>acupunctureHF@scrippshealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Christopher Suhar, MD</last_name>
      <phone>858-554-3300</phone>
    </contact_backup>
    <investigator>
      <last_name>Yu-Ming Ni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher Suhar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rajeev Mohan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 21, 2021</study_first_submitted>
  <study_first_submitted_qc>July 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2021</study_first_posted>
  <last_update_submitted>July 2, 2021</last_update_submitted>
  <last_update_submitted_qc>July 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Scripps Health</investigator_affiliation>
    <investigator_full_name>Yu-Ming Ni</investigator_full_name>
    <investigator_title>Cardiology Fellow</investigator_title>
  </responsible_party>
  <keyword>acupuncture</keyword>
  <keyword>midodrine</keyword>
  <keyword>fludrocortisone</keyword>
  <keyword>randomized controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

